durvalumab et trémélimumab
Thu, 17 Nov 2022 16:15:31 -0500
Le traitement combiné par trémélimumab pour injection et durvalumab est indiqué dans le traitement du carcinome hépatocellulaire inopérable.
Italiano
Thu, 17 Nov 2022 16:15:31 -0500
Le traitement combiné par trémélimumab pour injection et durvalumab est indiqué dans le traitement du carcinome hépatocellulaire inopérable.
The FDA recommends repeat testing following a negative result to reduce the risk that a COVID-19 infection could be missed, whether or not you have symptoms.
Omnipod DASH Insulin Management System’s Personal Diabetes Manager may have battery issues including swelling, fluid leakage, and extreme overheating.
Tue, 15 Nov 2022 16:39:59 -0500
Tue, 15 Nov 2022 16:16:52 -0500
Tue, 15 Nov 2022 14:23:22 -0500
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod® DASH Insulin M
Fri, 11 Nov 2022 11:40:51 -0500
Fri, 11 Nov 2022 11:40:49 -0500
Fri, 11 Nov 2022 11:40:49 -0500
80.211.154.110